Posttransplant bronchiolitis obliterans syndrome (BOS) results from a chronic immunological/inflammatory insult that leads to fibro-obliteration of the lumen of the allograft airways. The functional T-cell response that is associated with graft acceptance needs to be further clarified in humans. The aim of the present study was to assess the functional activity of peripheral CD4+ T lymphocytes in nine lung transplant recipients with BOS stage II or III (mean 5.4 years after transplant), in seven lung patients with stable clinical conditions (3.4 years posttransplant); and in six normal controls. Peripheral CD4+ T cells, obtained by magnetic bead vs negative purification, were studied using a computer-assisted enzyme-linked immunospot assay (ELISPOT) to assess the number of IFN-gamma-, interleukin (IL)5-, and IL10-gamma-producing cells (no./10(6) CD4+ cells) after allogeneic stimulation. The frequencies of IFN-gamma-producing CD4+ cells did not change significantly in stable patients compared to those with BOS. Interestingly in BOS, the number of IL5- and IL10-producing cells was significantly lower than in stable patients (P < or = .05), suggesting a possible role of these Th2 cytokines in the modulation of graft tolerance.

The frequency of Interleukin-10 and Interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted Lung

SOLARI, NADIA;MISERERE, SIMONA MARGHERITA;PELLEGRINI, CARLO;POZZI, ERNESTO;FIETTA, ANNA MARIA;MELONI, FEDERICA
2005-01-01

Abstract

Posttransplant bronchiolitis obliterans syndrome (BOS) results from a chronic immunological/inflammatory insult that leads to fibro-obliteration of the lumen of the allograft airways. The functional T-cell response that is associated with graft acceptance needs to be further clarified in humans. The aim of the present study was to assess the functional activity of peripheral CD4+ T lymphocytes in nine lung transplant recipients with BOS stage II or III (mean 5.4 years after transplant), in seven lung patients with stable clinical conditions (3.4 years posttransplant); and in six normal controls. Peripheral CD4+ T cells, obtained by magnetic bead vs negative purification, were studied using a computer-assisted enzyme-linked immunospot assay (ELISPOT) to assess the number of IFN-gamma-, interleukin (IL)5-, and IL10-gamma-producing cells (no./10(6) CD4+ cells) after allogeneic stimulation. The frequencies of IFN-gamma-producing CD4+ cells did not change significantly in stable patients compared to those with BOS. Interestingly in BOS, the number of IL5- and IL10-producing cells was significantly lower than in stable patients (P < or = .05), suggesting a possible role of these Th2 cytokines in the modulation of graft tolerance.
2005
Immunology incorporates cellular and molecular studies in immunology, as well as clinical research in immunopathology, infectious disease, autoimmunity, and allergy. Host-pathogen interactions in infectious disease, as well as experimental therapeutic applications of immunomodulating agents are also considered. Resources dealing primarily with the biology of microbial, viral, or parasitic pathogens are excluded and are covered in the Microbiology category.
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
37
5
2255
2256
2
Tematica Ex SIR: Genetica delle interstiziopatie (Classif. Ex SIR:Articoli su riviste ISI ) ISSN 0041-1345
Interleukin-10; Interleukin-5; tolerance of transplanted lung
8
info:eu-repo/semantics/article
262
Bianco, Am; Solari, Nadia; Miserere, SIMONA MARGHERITA; Pellegrini, Carlo; Vitulo, P; Pozzi, Ernesto; Fietta, ANNA MARIA; Meloni, Federica
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/134248
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact